Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.
Identifieur interne : 002339 ( Ncbi/Curation ); précédent : 002338; suivant : 002340Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.
Auteurs : G. Dennert [Allemagne] ; M. HorneberSource :
- The Cochrane database of systematic reviews [ 1469-493X ] ; 2006.
Descripteurs français
- KwdFr :
- Antinéoplasiques (effets indésirables), Antioxydants (usage thérapeutique), Complications postopératoires (), Diarrhée (), Essais contrôlés randomisés comme sujet, Humains, Lymphoedème (), Radiothérapie (effets indésirables), Sélénite de sodium (usage thérapeutique), Tumeurs (), Tumeurs (radiothérapie), Tumeurs (traitement médicamenteux).
- MESH :
- effets indésirables : Antinéoplasiques, Radiothérapie.
- radiothérapie : Tumeurs.
- traitement médicamenteux : Tumeurs.
- usage thérapeutique : Antioxydants, Sélénite de sodium.
- Complications postopératoires, Diarrhée, Essais contrôlés randomisés comme sujet, Humains, Lymphoedème, Tumeurs.
English descriptors
- KwdEn :
- Antineoplastic Agents (adverse effects), Antioxidants (therapeutic use), Diarrhea (prevention & control), Humans, Lymphedema (prevention & control), Neoplasms (drug therapy), Neoplasms (radiotherapy), Neoplasms (surgery), Postoperative Complications (prevention & control), Radiotherapy (adverse effects), Randomized Controlled Trials as Topic, Sodium Selenite (therapeutic use).
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- chemical , therapeutic use : Antioxidants, Sodium Selenite.
- adverse effects : Radiotherapy.
- drug therapy : Neoplasms.
- prevention & control : Diarrhea, Lymphedema, Postoperative Complications.
- radiotherapy : Neoplasms.
- surgery : Neoplasms.
- Humans, Randomized Controlled Trials as Topic.
Abstract
Selenium supplements are frequently used by cancer patients. Selenium is an essential trace element and is involved in antioxidant protection and redox-regulation in humans. Several adverse effects of radiotherapy and chemotherapy in cancer patients as well as cellular processes that maintain chronic lymphoedema have been linked to oxidative cell damage in the human body. Selenium has recently been investigated as a remedy against chemotherapy and radiotherapy-associated side effects as well as its effects on lymphoedema.
DOI: 10.1002/14651858.CD005037.pub2
PubMed: 16856073
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003932
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003932
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003932
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002339
Links to Exploration step
pubmed:16856073Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.</title>
<author><name sortKey="Dennert, G" sort="Dennert, G" uniqKey="Dennert G" first="G" last="Dennert">G. Dennert</name>
<affiliation wicri:level="1"><nlm:affiliation>Arbeitsgruppe Biologische Krebstherapie, Medizinische klinik 5, Prof.-Ernst-Nathan-Str. 1, Nuernberg, Germany D-90419. Gabriele.Dennert@klinikum-nuernberg.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Horneber, M" sort="Horneber, M" uniqKey="Horneber M" first="M" last="Horneber">M. Horneber</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16856073</idno>
<idno type="pmid">16856073</idno>
<idno type="doi">10.1002/14651858.CD005037.pub2</idno>
<idno type="wicri:Area/PubMed/Corpus">003932</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003932</idno>
<idno type="wicri:Area/PubMed/Curation">003932</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003932</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003932</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003932</idno>
<idno type="wicri:Area/Ncbi/Merge">002339</idno>
<idno type="wicri:Area/Ncbi/Curation">002339</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.</title>
<author><name sortKey="Dennert, G" sort="Dennert, G" uniqKey="Dennert G" first="G" last="Dennert">G. Dennert</name>
<affiliation wicri:level="1"><nlm:affiliation>Arbeitsgruppe Biologische Krebstherapie, Medizinische klinik 5, Prof.-Ernst-Nathan-Str. 1, Nuernberg, Germany D-90419. Gabriele.Dennert@klinikum-nuernberg.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Horneber, M" sort="Horneber, M" uniqKey="Horneber M" first="M" last="Horneber">M. Horneber</name>
</author>
</analytic>
<series><title level="j">The Cochrane database of systematic reviews</title>
<idno type="eISSN">1469-493X</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (adverse effects)</term>
<term>Antioxidants (therapeutic use)</term>
<term>Diarrhea (prevention & control)</term>
<term>Humans</term>
<term>Lymphedema (prevention & control)</term>
<term>Neoplasms (drug therapy)</term>
<term>Neoplasms (radiotherapy)</term>
<term>Neoplasms (surgery)</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Radiotherapy (adverse effects)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Sodium Selenite (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques (effets indésirables)</term>
<term>Antioxydants (usage thérapeutique)</term>
<term>Complications postopératoires ()</term>
<term>Diarrhée ()</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Sélénite de sodium (usage thérapeutique)</term>
<term>Tumeurs ()</term>
<term>Tumeurs (radiothérapie)</term>
<term>Tumeurs (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antioxidants</term>
<term>Sodium Selenite</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term>
<term>Radiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Diarrhea</term>
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antioxydants</term>
<term>Sélénite de sodium</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Complications postopératoires</term>
<term>Diarrhée</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Tumeurs</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Selenium supplements are frequently used by cancer patients. Selenium is an essential trace element and is involved in antioxidant protection and redox-regulation in humans. Several adverse effects of radiotherapy and chemotherapy in cancer patients as well as cellular processes that maintain chronic lymphoedema have been linked to oxidative cell damage in the human body. Selenium has recently been investigated as a remedy against chemotherapy and radiotherapy-associated side effects as well as its effects on lymphoedema.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002339 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002339 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:16856073 |texte= Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:16856073" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |